{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T11:45:19Z","timestamp":1771674319875,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We studied if pre-bronchodilator FEV<jats:sub>1<\/jats:sub>\/FEV<jats:sub>6<\/jats:sub> determinations with microspirometers by GPs improve the diagnostic process for COPD in a 6\u20138 month clustered randomised controlled trial in Dutch general practices (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.trialregister.nl\">http:\/\/www.trialregister.nl<\/jats:ext-link>: NTR4041). GPs allocated to microspirometry (MI) used COPD-6<jats:sup>\u00ae<\/jats:sup> microspirometers in patients \u226550 years old with a smoking history and respiratory complaints that could indicate undiagnosed COPD and ask to refer patients for full spirometry if MI was positive (FEV<jats:sub>1<\/jats:sub>\/FEV<jats:sub>6<\/jats:sub> &lt;0.73). Introduction of the COPD-6<jats:sup>\u00ae<\/jats:sup> was postponed in the usual care (UC) group. GPs of both study arms were asked to list all patients that fulfilled study criteria and at the end of the study we screened the electronic medical record system for number of patients that fulfilled study criteria and visited their GP within the study period. Main end point was a documented diagnostic conclusion of COPD within 3 months after the patient\u2019s visit. We used multilevel logistic regression with correction for relevant covariates. Next, we described the process of care. 21 practices (88 GPs) participated and 416 possible undiagnosed COPD patient visited these practices in the study period. 78 (of 192 visiting) subjects were listed by MI GPs and diagnostic conclusions were documented in 77%, compared to 61 listed (of 224 visiting) subjects and 44% with documented diagnostic conclusions by UC GPs (Odds Ratio: OR: 4.3, 95%CI: 1.6\u201311.5). Microspirometry improved the diagnostic process for possible underlying COPD in patients who consulted their GP with respiratory symptoms, but the majority of possible undiagnosed COPD patients remained unrecognised by GPs.<\/jats:p>","DOI":"10.1038\/s41533-018-0083-9","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T13:16:46Z","timestamp":1526476606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Point of care microspirometry to facilitate the COPD diagnostic process in primary care: a clustered randomised trial"],"prefix":"10.1038","volume":"28","author":[{"given":"Tjard R.","family":"Schermer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vatsolaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robbert","family":"Behr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke","family":"Grootens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riet","family":"Cretier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinier","family":"Akkermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joke","family":"Denis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Poels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-8273","authenticated-orcid":false,"given":"Lisette","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"83_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005611","volume":"4","author":"J Howick","year":"2014","unstructured":"Howick, J. et al. Current and future use of point-of-care tests in primary care: an international survey in Australia, Belgium, The Netherlands, the UK and the USA. BMJ Open 4, e005611 (2014).","journal-title":"BMJ Open"},{"key":"83_CR2","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management and prevention of COPD http:\/\/goldcopd.org\/global-strategy-diagnosis-management-prevention-copd-2016\/ (2016)."},{"key":"83_CR3","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1378\/chest.129.4.844","volume":"129","author":"M Lusuardi","year":"2006","unstructured":"Lusuardi, M. et al. A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study. Chest 129, 844\u2013852 (2006).","journal-title":"Chest"},{"key":"83_CR4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1183\/09031936.06.00019306","volume":"28","author":"PP Walker","year":"2006","unstructured":"Walker, P. P., Mitchell, P., Diamantea, F., Warburton, C. J. & Davies, L. Effect of primary-care spirometry on the diagnosis and management of COPD. Eur. Respir. J. 28, 945\u2013952 (2006).","journal-title":"Eur. Respir. J."},{"key":"83_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/COPD.S16396","volume":"6","author":"GD Salinas","year":"2011","unstructured":"Salinas, G. D. et al. Barriers to adherence to chronic obstructive pulmonary disease guidelines by primary care physicians. Int. J. Chron. Obstruct. Pulmon. Dis. 6, 171\u2013179 (2011).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"83_CR6","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1136\/thx.2007.085456","volume":"63","author":"M Bednarek","year":"2008","unstructured":"Bednarek, M., Maciejewski, J., Wozniak, M., Kuca, P. & Zielinski, J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 63, 402\u2013407 (2008).","journal-title":"Thorax"},{"key":"83_CR7","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1136\/thx.2006.064410","volume":"61","author":"L Shahab","year":"2006","unstructured":"Shahab, L., Jarvis, M. J., Britton, J. & West, R. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax 61, 1043\u20131047 (2006).","journal-title":"Thorax"},{"key":"83_CR8","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1378\/chest.127.5.1560","volume":"127","author":"J Vandevoorde","year":"2005","unstructured":"Vandevoorde, J., Verbanck, S., Schuermans, D., Kartounian, J. & Vincken, W. FEV1\/FEV6 and FEV6 as an alternative for FEV1\/FVC and FVC in the spirometric detection of airway obstruction and restriction. Chest 127, 1560\u20131564 (2005).","journal-title":"Chest"},{"key":"83_CR9","doi-asserted-by":"publisher","first-page":"14033","DOI":"10.1038\/npjpcrm.2014.33","volume":"24","author":"L van den Bemt","year":"2014","unstructured":"van den Bemt, L. et al. Diagnostic accuracy of pre-bronchodilator FEV1\/FEV6 from microspirometry to detect airflow obstruction in primary care: a randomised cross-sectional study. NPJ Prim. Care Respir. Med. 24, 14033 (2014).","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"83_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.4104\/pcrj.2011.00040","volume":"20","author":"P Frith","year":"2011","unstructured":"Frith, P. et al. Simplified COPD screening: validation of the PiKo-6(R) in primary care. Prim. Care. Respir. J. 20, 190\u2013198 (2011).","journal-title":"Prim. Care. Respir. J."},{"key":"83_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4104\/pcrj.2011.00104","volume":"21","author":"J Thorn","year":"2012","unstructured":"Thorn, J. et al. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim. Care. Respir. J. 21, 159\u2013166 (2012).","journal-title":"Prim. Care. Respir. J."},{"key":"83_CR12","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.3399\/bjgp12X625111","volume":"62","author":"M Miravitlles","year":"2012","unstructured":"Miravitlles, M. et al. Difficulties in differential diagnosis of COPD and asthma in primary care. Br. J. Gen. Pract. 62, e68\u2013e75 (2012).","journal-title":"Br. J. Gen. Pract."},{"key":"83_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145571","volume":"11","author":"C Represas-Represas","year":"2016","unstructured":"Represas-Represas, C. et al. Screening for chronic obstructive pulmonary disease: validity and reliability of a portable device in non-specialized healthcare settings. PLoS ONE 11, e0145571 (2016).","journal-title":"PLoS ONE"},{"key":"83_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005683","volume":"95","author":"JK Kim","year":"2016","unstructured":"Kim, J. K. et al. Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry. Medicine 95, e5683 (2016).","journal-title":"Medicine"},{"key":"83_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15412555.2016.1239703","volume":"14","author":"M Llordes","year":"2017","unstructured":"Llordes, M. et al. Which is the best screening strategy for COPD among smokers in primary care? COPD 14, 43\u201351 (2017).","journal-title":"COPD"},{"key":"83_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4104\/pcrj.2013.00070","volume":"22","author":"JA Dirven","year":"2013","unstructured":"Dirven, J. A. et al. Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Prim. Care. Respir. J. 22, 331\u2013337 (2013).","journal-title":"Prim. Care. Respir. J."},{"key":"83_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.4104\/pcrj.2013.00071","volume":"22","author":"JA Dirven","year":"2013","unstructured":"Dirven, J. A. et al. Early detection of COPD in general practice: implementation, workload and socioeconomic status. A mixed methods observational study. Prim. Care. Respir. J. 22, 338\u2013343 (2013).","journal-title":"Prim. Care. Respir. J."},{"key":"83_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4104\/pcrj.2011.00038","volume":"20","author":"L Sichletidis","year":"2011","unstructured":"Sichletidis, L. et al. A combination of the IPAG questionnaire and PiKo-6(R) flow meter is a valuable screening tool for COPD in the primary care setting. Prim. Care. Respir. J. 20, 184\u2013189 (2011).","journal-title":"Prim. Care. Respir. J."},{"key":"83_CR19","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"Pocock, S. J. & Simon, R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31, 103\u2013115 (1975).","journal-title":"Biometrics"},{"key":"83_CR20","unstructured":"Vitalograph copd-6. User Training Manual https:\/\/vitalograph.com\/downloads\/view\/28 (2007)."},{"key":"83_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller, M. R. et al. Standardisation of spirometry. Eur. Respir. J. 26, 319\u2013338 (2005).","journal-title":"Eur. Respir. J."},{"key":"83_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer, P. H. et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur. Respir. J. 40, 1324\u20131343 (2012).","journal-title":"Eur. Respir. J."},{"key":"83_CR23","unstructured":"Volksgezondheidenzorg.info: Prevalentie COPD in huisartsenpraktijk, https:\/\/www.volksgezondheidenzorg.info\/onderwerp\/copd\/cijfers-context\/huidige-situatie#node-prevalentie-copd-huisartsenpraktijk (2016)."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-018-0083-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-018-0083-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-018-0083-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T22:49:57Z","timestamp":1671576597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-018-0083-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["83"],"URL":"https:\/\/doi.org\/10.1038\/s41533-018-0083-9","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"7 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.S. has received research grants for studies in chronic respiratory diseases from GlaxoSmithKline, Novartis and Boehringer Ingelheim and is a member of the primary care scientific advisory board of Boehringer Ingelheim. Moreover, he is an editorial board member of the <i>npj Primary Care Respiratory Medicine<\/i>. The remaining authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}